glp 1 agonist moa GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Cardiovascular Protection with a Long-Acting

Weekly injections (e.g., semaglutide, tirzepatide, dulaglutide, and exenatide ER) offer convenience but still require careful titration and consistent day-of-week use

In the years these drugs have been in shortage, a cottage industry of telehealth companies and medical spas has sprung up offering compounded GLP-1 products for a fraction of the cost of the brand-name counterparts

doi: 10.3390/cells11132023

95% CI 1.39 to 2.44

These studies demonstrate that allulose has a protective effect on hepatic outcomes derivative of a Western diet

Can dual incretin receptor agonists exert better cardiovascular protection than selective GLP-1 receptor agonists